Regulations for Pharmaceuticals Post Brexit
The European Commission has published a Communication to prepare for the end of the transition period. The document is appropriately entitled "Getting ready for changes - Communication on readiness at the end [...]
Pharma Industry Awards 2020
We’re pleased to announce that MIAS Pharma Ltd has been shortlisted for Pharma Supplier of the Year in this years Pharma Industry awards. We look forward to a great evening and catching [...]
A Message from MIAS Pharma (COVID – 19)
I wish to update you on MIAS Pharma ltd position regarding COVID-19. The World Health Organisation formally declared COVID-19 a pandemic, and the European Centre for Disease Prevention and Control (ECDC) updated its guidelines around [...]
Good Distribution Practice (GDP): Issue of Theft
The wholesale distribution of medicinal products and active substances is an important activity. The quality and the integrity of medicinal products can be affected by a lack of adequate control. The quality, [...]
Good Distribution Practice (GDP): Issue of Theft
The wholesale distribution of medicinal products and active substances is an important activity. The quality and the integrity of medicinal products can be affected by a lack of adequate control. The quality, [...]
Pharma giant tackling counterfeit drugs using blockchain
Fighting counterfeit drugs with blockchain technology… The Asia-Pacific pharmaceutical giant Zuellig pharma is using a blockchain platform by SAP to assist consumers identify the medicines place of origin. With 1 in 10 [...]
Get Social